Meet Diane Bodurka, M.D.
Diane C. Bodurka, M.D., MPH
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
About Dr. Bodurka
Dr. Diane Bodurka is a nationally recognized gynecologic oncologist who has cared for patients at MD Anderson since 1996. As Vice President and Chief Education & Training Officer, she also shapes the future of medical education at our institution.
Dr. Bodurka leads numerous patient studies, along with clinical trials for ovarian cancer treatment. She has written more than 100 peer-reviewed articles and numerous book chapters, exemplifying leadership in academia. Her expertise spans diverse research areas, including quality of life issues, patient-reported outcomes, health services research, and innovative technology applications in oncology.
Dr. Bodurka's clinical excellence has earned her recognition among America's Top Doctors and U.S. News Top Doctors. Her career highlights include directing the MD Anderson Cancer Center Gynecologic Oncology Fellowship Program and leading education and training initiatives at departmental and institutional levels. Through her leadership, Dr. Bodurka continues to advance medical education and research, embodying a steadfast commitment to health care delivery.
Present Title & Affiliation
Primary Appointment
Professor, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Vice President/Chief Education & Training Officer, The University of Texas MD Anderson Cancer Center, Houston, TX
Designated Institutional Official, The University of Texas MD Anderson Cancer Center, Houston, TX
Accreditation Liaison, Southern Association of Colleges and Schools - Commission on Colleges, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2014 | The University of Texas School of Public Health, Houston, TX, USA, MPH, Health Services Organization |
| 1990 | Georgetown University School of Medicine, Washington, USA, MD, Medicine |
| 1983 | The University of California, Los Angeles, CA, USA, BS, Psychobiology |
Postgraduate Training
| 2024-2024 | 2024 UHN Virtual Interprofessional Teaching & Learning (VITAL), The University of Toronto Center for Advancing Collaborative Healthcare & Education, Toronto |
| 2023-2024 | Council of Deans Fellowship Program, Association of American Medical Colleges, Washinton D.C, DC |
| 2022-2023 | Research Fellowship, Data Equity Fellowship, Northwest Commission on Colleges – Southern Association of Colleges and Schools Commission on Colleg, Redmond, WA |
| 2022-2022 | Promoting Professionalism, Vanderbilt University Medical Center, Nashville, TN |
| 2020-2020 | MD Anderson Coach RICE Program, The University of Texas MD Anderson Cancer Center Leadership Institute in conjunction with The Rice, Houston, TX |
| 2020-2020 | Leading Difference for High Performance, Leading Difference for High Performance, Harvard Business School, Boston, MA |
| 2005-2005 | Faculty Leadership Academy, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1994-1996 | Fellowship, Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1990-1994 | Internship and Residency, Obstetrics and Gynecology, The University of Alabama, Birmingham, AL |
Board Certifications
| 1999 | American Board of Obstetrics and Gynecology |
| 1997 | American Board of Obstetrics and Gynecology |
Experience & Service
Academic Appointments
The University of Texas Distinguished Teaching Professor, The University of Texas System, Austin, TX, 2012 - Present
Voluntary Assistant Clinical Professor, The University of California, San Diego, School of Medicine, San Diego, CA, 2005 - 2010
Term Tenure Awarded, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - Present
Associate Professor, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003 - 2008
Assistant Professor (tenure track), Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2000 - 2003
Assistant Professor, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center (non-tenure track), Houston, TX, 1996 - 2000
Junior Faculty Associate, Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1994 - 1996
Administrative Appointments/Responsibilities
Member, Executive Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - Present
Director, Health Services Research Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010 - 2013
Medical Director, Advanced Practice Nurse Midlevel Providers, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2011
Rotation Coordinator, Step-Up Biomedical Engineering/Bioengineering Student Interns, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2010
Co-Director, Career Development Program for the Uterine SPORE, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2007 - Present
Director, Gynecologic Oncology Rotation for Hematology/Oncology Fellows, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Chair, Fellowship Planning Committee, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2012
Director, Fellowship Training Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2012
Co-Director, Ovarian Cancer Screening Clinic, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2005
Assistant Director, Fellowship Training Program, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2001
Program Director, Resident Rotations, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2012
Director, Ovarian Cancer Screening Clinic, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1996 - 2001
Other Appointments/Responsibilities
Member, Comparative Effectiveness Research Working Group, Gynecologic Oncology Group, Philadelphia, PA, 2010 - 2011
Member, Quality of Life Committee, Gynecologic Oncology Group, Philadelphia, PA, 1999 - 2009
Member, Data Management Committee, Gynecologic Oncology Group, Philadelphia, PA, 1998 - 2009
Institutional Committee Activities
Member, Trainee Excellence Awards Committee, 2010 - Present
Member, Patient Care Operations Team (PCOT), Department of Gynecologic Oncology and Reproductive Medicine, 2009 - 2012
Chair, Distinguished Alumnus Award Subcommittee of the MD Anderson Alumni and Faculty Association, 2008 - 2018
Member, Academic Affairs & Medical Education Working Group, 2008 - 2010
Member, Gynecology Center Survivorship Program Project, Department of Gynecologic Oncology and Reproductive Medicine, 2008 - 2011
Member, Search Committee, Chair of Department of Surgical Oncology, 2008 - 2010
Alternate Departmental Representative, Department of Gynecologic Oncology and Reproductive Medicine, Credentials Committee of the Medical Staff, 2008 - 2011
Member, Continuing Medical Education Advisory Committee, 2008 - 2010
Member, Multidisciplinary Disposition Conference Redesign Group, Department of Gynecologic Oncology and Reproductive Medicine, 2008 - 2011
Member, Step-Up Advisory Board, 2008 - 2010
Member, MD Anderson Cancer Center Alumni and Faculty Association Steering Committee, 2007 - 2018
Chair, Graduate Medical Education Committee, 2006 - 2007
Member, Executive Committee, Blanton-Davis Ovarian Cancer Research Program, Department of Gynecologic Oncology and Reproductive Medicine, 2006 - Present
Member, Faculty Achievement Awards Committee, 2006 - 2008
Member, Education Council, 2006 - 2007
Member, Fellowship Steering Committee, Hematology/Oncology Fellowship Program, Division of Cancer Medicine, 2006 - 2012
Chair, Quality of Life, Health Services Research and Survivorship Working Group, Department of Gynecologic Oncology and Reproductive Medicine, 2004 - 2009
Vice-Chair, Graduate Medical Education Committee, 2003 - 2005
Vice-Chair Elect, Graduate Medical Education Committee, 2001 - 2003
Member, Ethel Fleming Arceneaux Award Selection Committee, 2001 - 2001
Member, Institutional Review Board, 2000 - 2003
Chair, Admissions Subcommittee, Department of Gynecologic Oncology and Reproductive Medicine, 2000 - 2012
Member, Psychosocial, Behavioral and Health Services Research Committee, 1999 - 2001
Member, Search Committee, Director of Human Clinical Cancer Genetics, 1999 - 2001
Member, Faculty Senate, 1997 - 2001
Member, Medical Practice Subcommittee of the Executive Committee, 1997 - 2005
Consultantships
Oncology.com, Washington, D.C, 2000 - 2010
Web.md, Washington, D.C, 2000 - 2010
Honors & Awards
| 2023 | Castle Connolly's Top Doctors |
| 2023 | Texas Super Doctors |
| 2023 | Commitment to Mentoring Award |
| 2021 | Commitment to Mentoring Award |
| 2020 | Texas Super Doctors |
| 2020 | Excellence in LEADership Award, The University of Texas MD Anderson Cancer Center |
| 2019 | Alpha Eta Honor Society Honorary Membership, The University of Texas MD Anderson Cancer Center |
| 2019 | Top 1% of America's Most Honored Professionals, The American Registry |
| 2019 | Texas Super Doctors |
| 2019 | TX Top Doctor, TX Top Docs |
| 2019 | Castle Connolly's Exceptional Women in Medicine |
| 2019 | Finalist Strategy Competition, Harvard Business School |
| 2018 | Awesome Job Award, The University of Texas MD Anderson Cancer Center |
| 2017 | Commitment to Mentoring Award |
| 2017 | Houstonia 2017 Top Doctors |
| 2015 | Texas Super Doctors |
| 2013 | Educator of the Month, The University of Texas MD Anderson Cancer Center, December |
| 2013 | Ashbel Smith Professor, The University of Texas MD Anderson Cancer Center |
| 2012 | Distinguished Teaching Professor, The University of Texas System |
| 2011 | The William Randolph Hearst Foundations Faculty Achievement Award in Education, MD Anderson Cancer Center |
| 2011 | International Who's Who of Professional & Business Women's Hall of Fame |
| 2011 | U. S. News Top Doctors |
| 2010 | Association of Professors of Gynecology and Obstetrics Excellence in Teaching Award |
| 2009 | International Who's Who of Professional & Business Women |
| 2009 | Fellow, American Gynecological and Obstetrical Society |
| 2009 | America's Top Oncologists |
| 2009 | Distinguished Teaching Professor, Elected, The University of Texas Academy of Health Science Education |
| 2008 | Best Doctors in America® |
| 2008 | Houston's Top Doctors |
| 2008 | Women of the Year in Medicine and Healthcare |
| 2007 | Educator of the Month, The University of Texas MD Anderson Cancer Center, February |
| 2005 | APGO/Solvay Education Scholar |
| 2005 | Castle Connolly's America's Top Doctors |
| 2004 | Educator of the Month, The University of Texas MD Anderson Cancer Center, May |
| 2004 | America's Top Obstetricians and Gynecologists |
| 2003 | Outstanding Educator, The University of Texas MD Anderson Cancer Center |
| 2000 | Finalist, Julie and Ben Rogers Award for Excellence in Education, The University of Texas MD Anderson Cancer Center |
| 2000 | ACOG/Wyeth-Ayerst Fellowship in Women's Health Policy |
| 1994 | Alpha Omega Alpha, The University of Alabama at Birmingham |
| 1994 | Administrative Chief Resident, The University of Alabama at Birmingham |
| 1994 | Best Teaching Resident, The University of Alabama at Birmingham |
Selected Publications
Peer-Reviewed Articles
- Franco Vega MC, Ait Aiss M, Smith M, George M, Day L, Mbadugha A, Niangar Z, Bodurka DC. Improving handoff with the implementation of I-PASS at a tertiary oncology hospital. BMJ Open Qual 12(4), 2023. PMID: 37802542.
- Prescott LS, Vergote I, Sun CC, Bodurka DC, Coleman RL. Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort. Int J Gynecol Cancer 33(1):1-9, 2023. e-Pub 2023. PMID: 36356982.
- Hinchcliff E, Gunther J, Ponnie AE, Bednarski B, Onstad M, Shafer A, Frumovitz M, Jazaeri A, Urbauer D, Bodurka DC. A Not So Perfect Score: Factors Associated with the Rate of Straight Line Scoring in Oncology Training Programs. J Cancer Educ 37(3):615-620, 2022. PMID: 32839894.
- Zhukovsky DS, Haider A, Williams JL, Naqvi S, Joshi N, Mills S, Soliman PT, Mathew B, Bodurka DC, Meyer LA, Westin S, Frumovitz M, Nowitz MB, Archie L, Fenton S, Lang K, Boving V, Bruera E. An Integrated Approach to Selecting a Prepared Medical Decision Maker. J Pain Symptom Manage 61(6):1305-1310, 2021. e-Pub 2020. PMID: 33348030.
- Bailey CD, Previs R, Fellman BM, Zaid T, Huang M, Brown A, Enbaya A, Balakrishnan N, Broaddus RR, Bodurka DC, Soliman P, Fleming ND, Nick A, Sood AK, Westin SN. Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer. Int J Gynecol Cancer 31(2):232-237, 2021. PMID: 33122243.
- Coleman RL, Hu W, Soliman P, Nick A, Ramirez PT, Westin SN, Garcia ME, Zhu Z, Palancia J, Fellman BM, Yuan Y, Ram P, Bischoff F, Schmeler K, Bodurka DC, Meyer LA, Sood AK. Dasatinib, paclitaxel, and carboplatin in women with advanced-stage or recurrent endometrial cancer: A pilot clinical and translational study. Gynecol Oncol. e-Pub 2021. PMID: 33551196.
- Westin SN, Fellman B, Sun CC, Broaddus RR, Woodall ML, Pal N, Urbauer DL, Ramondetta LM, Schmeler KM, Soliman PT, Fleming ND, Burzawa JK, Nick AM, Milbourne AM, Yuan Y, Lu KH, Bodurka DC, Coleman RL, Yates MS. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer. Am J Obstet Gynecol 224(2):191.e1-191.e15, 2021. e-Pub 2020. PMID: 32805208.
- Chelariu-Raicu A, Levenback C, Slomovitz B, Wolf J, Bodurka DC, Kavanagh JJ, Morrison C, Gershenson D, Coleman R. Phase Ib/II study of weekly topotecan and daily gefitinib in patients with platinum resistant ovarian, peritoneal, or fallopian tube cancer. Int J Gynecol Cancer. e-Pub 2020. PMID: 33037105.
- Berkman AM, Livingston JA, Merriman K, Hildebrandt M, Wang J, Dibaj S, McQuade J, You N, Ying A, Barcenas C, Bodurka DC, DePombo A, Lee HJ, de Groot J, Roth M. Long-term survival among 5-year survivors of adolescent and young adult cancer. Cancer 126(16):3708-3718, 2020. e-Pub 2020. PMID: 32484922.
- Zhukovsky DS, Soliman PT, Mathew B, Mills S, Bodurka DC, Frumovitz M, Meyer LA, Westin S, Nowitz M, Archie L, Fenton S, Lang K, Williams JL, Boving V, Bruera E. Systematic Approach to Selecting and Preparing a Medical Power of Attorney in the Gynecologic Oncology Center. J Oncol Pract 15(12):JOP1900109, 2019. e-Pub 2019. PMID: 31613720.
- Prescott LS, Taylor JS, Enbaya A, Marten CA, Myers KN, Meyer LA, Ramirez PT, Levenback CF, Bodurka DC, Schmeler KM. Choosing Wisely: Decreasing the incidence of perioperative blood transfusions in gynecologic oncology. Gynecol Oncol 153(3):597-603, 2019. e-Pub 2019. PMID: 30872025.
- Polansky MN, Govaerts MJB, Stalmeijer RE, Eid A, Bodurka DC, Dolmans DHJM. Exploring the effect of PAs on physician trainee learning: An interview study. JAAPA 32(5):47-53, 2019. PMID: 31033715.
- Taylor JS, Zhang N, Rajan SS, Chavez-MacGregor M, Zhao H, Niu J, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecol Oncol 152(3):452-458, 2019. PMID: 30876488.
- Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol 152(3):514-521, 2019. PMID: 30876497.
- Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA. Corrigendum to "Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study" [Gynecol. Oncol. 151 (2018) 18-23]. Gynecol Oncol 152(1):220, 2019. e-Pub 2018. PMID: 30360899.
- Gonzalez CE, Brito-Dellan N, Banala SR, Rubio D, Ait Aiss M, Rice TW, Chen K, Bodurka DC, Escalante CP. Handoff Tool Enabling Standardized Transitions Between the Emergency Department and the Hospitalist Inpatient Service at a Major Cancer Center. Am J Med Qual 33(6):629-636, 2018. e-Pub 2018. PMID: 29779398.
- Olawaiye AB, Java JJ, Krivak TC, Friedlander M, Mutch DG, Glaser G, Geller M, O'Malley DM, Wenham RM, Lee RB, Bodurka DC, Herzog TJ, Bookman MA. Does adjuvant chemotherapy dose modification have an impact on the outcome of patients diagnosed with advanced stage ovarian cancer? An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol 151(1):18-23, 2018. e-Pub 2018. PMID: 30135020.
- Armbruster SD, Sun CC, Westin SN, Bodurka DC, Ramondetta L, Meyer LA, Soliman PT. Prospective Assessment of Patient - Reported Outcomes in Gynecologic Cancer Patients Before and After Pelvic Exenteration. Gynecol Oncol 149(3):484-490, 2018. e-Pub 2018. PMID: 29622276.
- Schlumbrecht M, Sun C, Huang M, Milbourne A, Bodurka DC. Gynecologic Cancer Survivor Preferences for Long-Term Surveillance. BMC Cancer 18(1):375, 2018. e-Pub 2018. PMID: 29614979.
- Shah JS, Guerra R, Bodurka DC, Sun CC, Chisholm GB, Woodard TL. Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members. Gynecol Oncol 147(3):497-502, 2017. e-Pub 2017. PMID: 28941656.
- Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Support Care Cancer 25(6):1985-1991, 2017. e-Pub 2017. PMID: 28175997.
- Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, Lairson DR, Giordano SH. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol 35(16):JCO2016702894, 2017. e-Pub 2017. PMID: 28388292.
- Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer. Int J Gynecol Cancer. e-Pub 2017. PMID: 28574929.
- Shinn EH, Valentine A, Baum G, Carmack C, Kilgore K, Bodurka DC, Basen-Engquist K. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecol Oncol 145(3):562-568, 2017. e-Pub 2017. PMID: 28400146.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer 27(4):838-846, 2017. PMID: 28399031.
- Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Surgery 161(3):869-875, 2017. e-Pub 2016. PMID: 27825699.
- Taylor JS, Marten CA, Munsell MF, Sun CC, Potts KA, Burzawa JK, Nick AM, Meyer LA, Myers K, Bodurka DC, Aloia TA, Levenback CF, Lairson DR, Schmeler KM. The DISINFECT Initiative: Decreasing the Incidence of Surgical INFECTions in Gynecologic Oncology. Ann Surg Oncol 24(2):362-368, 2017. e-Pub 2016. PMID: 27573526.
- Taylor JS, Marten CA, Potts KA, Cloutier LM, Cain KE, Fenton SL, Tatum TN, James DA, Myers KN, Hubbs CA, Burzawa JK, Vachhani S, Nick AM, Meyer LA, Graviss LS, Ware KM, Park AK, Aloia TA, Bodurka DC, Levenback CF, Schmeler KM. What Is the Real Rate of Surgical Site Infection?. J Oncol Pract 12(10):e878-e883, 2016. e-Pub 2016. PMID: 27460495.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC. Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecol Oncol 142(3):525-30, 2016. e-Pub 2016. PMID: 27439968.
- Moroney J, Wheler J, Hong D, Naing A, Falchook G, Bodurka DC, Coleman R, Lu K, Xiao L, Kurzrock R. Phase I clinical trials in 85 patients with gynecologic cancer: The MD Anderson Cancer Center experience. Gynecol Oncol 117(3):467-72, 2010. e-Pub 2010. PMID: 20347123.
- Schmeler KM, Jhingran A, Iyer RB, Sun CC, Eifel PJ, Soliman PT, Ramirez PT, Frumovitz M, Bodurka DC, Sood AK. Pelvic fractures after radiotherapy for cervical cancer: Implications for Survivors. Cancer 116(3):625-630, 2010. e-Pub 2010. PMID: 20052724.
- Tung CS, Sun CC, Schlumbrecht MP, Meyer LA, Bodurka DC. Survival after intestinal perforation: Can it be predicted?. Gynecol Oncol 115(3):349-53, 2009. e-Pub 2009. PMID: 19765809.
- Shinn EH, Taylor CL, Kilgore K, Valentine A, Bodurka DC, Kavanagh J, Sood A, Li Y, Basen-Engquist K. Associations with worry about dying and hopelessness in ambulatory ovarian cancer patients. Palliat Support Care 7(3):299-306, 2009. PMID: 19788771.
- Hoffman MS, Bodurka DC. Surgical education and training program development for gynecologic oncology: American perspective. Gynecol Oncol 114(2 Suppl):S47-51, 2009. PMID: 19573707.
- Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Concurrent chemoradiation in the routine management of patients with cervical cancer: Does marital status matter?. Int J Gynecol Cancer 19(6):1107-1112, 2009. PMID: 19820377.
- Gershenson DM, Sun CC, Bodurka DC, Coleman RL, Lu KH, Sood AK, Deavers M, Malpica AL, Kavanagh JJ. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant. Gynecol Oncol 114(1):48-52, 2009. e-Pub 2009. PMID: 19361839.
- Litton JK, Westin SN, Ready K, Sun CC, Peterson SK, Meric-Bernstam F, Gonzalez-Angulo AM, Bodurka DC, Lu KH, Hortobagyi GN, Arun BK. Perception of screening and risk-reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer 115(8):1598-604, 2009. PMID: 19280625.
- Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L, Hughes D, Carmack Taylor C. Physical activity and obesity in endometrial cancer survivors: Associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 200(3):288.e1-e8, 2009. e-Pub 2008. PMID: 19110220.
- Westin SN, Lacour RA, Urbauer DL, Luthra R, Bodurka DC, Lu KH, Broaddus RR. Carcinoma of the lower uterine segment: A newly described association with Lynch Syndrome. J Clin Oncol 26(36):5965-71, 2008. e-Pub 2008. PMID: 19001318.
- Frumovitz M, Soliman PT, Greer M, Schmeler KM, Moroney J, Bodurka DC, Ramirez PT. Laparoscopy training in gynecologic oncology fellowship programs. Gynecol Oncol 111(2)(2):197-201, 2008. e-Pub 2008. PMID: 18804849.
- Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer 18(4):660-669, 2008. e-Pub 2007. PMID: 17892451.
- Miller DS, Blessing JA, Bodurka DC, Bonebrake AJ, Schorge JO. Evaluation of pemetrexed (Alimta, LY231514) as second line chemotherapy in persistent or recurrent carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group. Gynecol Oncol 110(1):65-70, 2008. e-Pub 2008. PMID: 18455781.
- Batista LI, Lu KH, Beahm EK, Arun BK, Bodurka DC, Meric-Bernstam F. Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome. BMC Cancer 8:101, 2008. PMID: 18410690.
- Schmeler KM, Sun CC, Bodurka DC, Deavers MT, Malpica A, Coleman RL, Ramirez PT, Gershenson DM. Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol 108(3):510-4, 2008. e-Pub 2007. PMID: 18155273.
- Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 70(1)(1):118-25, 2008. e-Pub 2007. PMID: 17869451.
- Shvartsman HS, Sun CC, Bodurka DC, Mahajan V, Crispens M, Lu KH, Deavers MT, Malpica A, Silva EG, Gershenson DM. Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma. Gynecol Oncol 105(3):625-9, 2007. e-Pub 2007. PMID: 17320156.
- Frumovitz M, Bodurka DC, Broaddus RR, Coleman RL, Sood AK, Gershenson DM, Burke TW, Levenback CF. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 104(1):100-3, 2007. e-Pub 2006. PMID: 16963111.
- Sun CC, Ramirez PT, Bodurka DC. Quality of life for patients with epithelial ovarian cancer. Nat Clin Pract Oncol 4(1):18-29, 2007. PMID: 17183353.
- Slomovitz BM, Sun CC, Frumovitz M, Soliman PT, Schmeler KM, Pearson HC, Berenson A, Ramirez PT, Lu KH, Bodurka DC. Are women ready for the HPV vaccine?. Gynecol Oncol 103(1)(1):151-4, 2006. e-Pub 2006. PMID: 16551476.
- Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Obstet Gynecol 108(3 Pt 1):515-20, 2006. PMID: 16946209.
- Wolf JK, Bodurka DC, Verschraegen C, Sun CC, Branham D, Jenkins AD, Atkinson N, Gershenson DM. A phase II trial of oral capecitabine in patients with platinum- and taxane-refractory ovarian, fallopian tube, or peritoneal cancer. Gynecol Oncol 102(3):468-74, 2006. e-Pub 2006. PMID: 16516276.
- Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol 108(2):361-8, 2006. PMID: 16880307.
- Elting LS, Cooksley C, Bekele BN, Frumovitz M, Avritscher EB, Sun C, Bodurka DC. Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. Cancer 106(11):2452-8, 2006. PMID: 16639738.
- Coleman RL, Broaddus RR, Bodurka DC, Wolf JK, Burke TW, Kavanagh JJ, Levenback CF, Gershenson DM. Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers. Gynecol Oncol 101(1):126-31, 2006. e-Pub 2005. PMID: 16271384.
- Seiden MV, Gordon AN, Bodurka DC, Matulonis UA, Penson RT, Reed E, Alberts DS, Weems G, Cullen M, McGuire WP. A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecol Oncol 101(1):55-61, 2006. e-Pub 2005. PMID: 16260029.
- Earle CC, Schrag D, Neville BA, Yabroff KR, Topor M, Fahey A, Trimble EL, Bodurka DC, Bristow RE, Carney M, Warren JL. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98(3):172-80, 2006. PMID: 16449677.
- Frumovitz M, Sun CC, Schover LR, Munsell MF, Jhingran A, Wharton JT, Eifel P, Bevers TB, Levenback CF, Gershenson DM, Bodurka DC. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 23(30):7428-36, 2005. PMID: 16234510.
- Lyman GH, Giuliano AE, Somerfield MR, Benson AB, Bodurka DC, Burstein HJ, Cochran AJ, Cody HS, Edge SB, Galper S, Hayman JA, Kim TY, Perkins CL, Podoloff DA, Sivasubramaniam VH, Turner RR, Wahl R, Weaver DL, Wolff AC, Winer EP. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23(30):7703-20, 2005. e-Pub 2005. PMID: 16157938.
- Sun CC, Bodurka DC, Weaver CB, Rasu R, Wolf JK, Bevers MW, Smith JA, Wharton JT, Rubenstein EB. Rankings and symptom assessments of side effects from chemotherapy: Insights from experienced patients with ovarian cancer. Support Care Cancer 13(4):219-27, 2005. e-Pub 2004. PMID: 15538640.
- Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95(3):463-8, 2004. PMID: 15581947.
- Frumovitz M, Slomovitz BM, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Endometrial Cancer: To stage or not to stage?. J Amer Coll Surg 199:388-393, 2004.
- Frumovitz M, Ramirez PT, Greer M, Gregurich MA, Wolf J, Bodurka DC, Levenback C. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol Oncol 94(3):746-53, 2004. PMID: 15350368.
- Frumovitz M, Slomovitz BM, Singh DK, Broaddus RR, Abrams J, Sun CC, Bevers M, Bodurka DC. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 199(3):388-93, 2004. PMID: 15325608.
- Slomovitz BM, Sun CC, Ramirez PT, Bodurka DC, Diaz P, Lu KH. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Obstet Gynecol 104(2):255-60, 2004. PMID: 15291996.
- Smith JA, Kindo CC, Kurian S, Whitaker LM, Burke C, Wachel B, Sun CC, Weaver CL, Danielson MG, Fitzgerald MA, Munsell M, Zandstra FA, Bodurka DC. Evaluation of patient chemotherapy education in a gynecology oncology center. Support Care Cancer 12(8):577-83, 2004. e-Pub 2004. PMID: 15168104.
- Wolf JK, Bodurka DC, Gano JB, Deavers M, Ramondetta L, Ramirez PT, Levenback C, Gershenson DM. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer. Gynecol Oncol 94(2):442-8, 2004. PMID: 15297186.
- Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: An exploratory study. Int J Gynecol Cancer 14(4):580-8, 2004. PMID: 15304150.
- Carmack Taylor CL, Basen-Engquist K, Shinn EH, Bodurka DC. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22(5):881-9, 2004. PMID: 14990644.
- Basen-Engquist K, Paskett ED, Buzaglo J, Miller SM, Schover L, Wenzel LB, Bodurka DC. Cervical cancer. Cancer 98(9 Suppl):2009-14, 2003. PMID: 14603537.
- Bodurka DC, Levenback C, Wolf JK, Gano J, Wharton JT, Kavanagh JJ, Gershenson DM. Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. J Clin Oncol 21(2):291-7, 2003. PMID: 12525521.
- Ramondetta LM, Bodurka DC, Tortolero-Luna G, Gordinier M, Wolf JK, Gershenson DM, Sciscione AC. Mentorship and productivity among gynecologic oncology fellows. J Cancer Educ 18(1):15-9, 2003. PMID: 12825629.
- Sun CC, Bodurka DC, Donato ML, Rubenstein EB, Borden CL, Basen-Engquist K, Munsell MF, Kavanagh JJ, Gershenson DM. Patient preferences regarding side effects of chemotherapy for ovarian cancer: Do they change over time?. Gynecol Oncol 87(1):118-28, 2002. PMID: 12468352.
- Eifel PJ, Jhingran A, Bodurka DC, Levenback C, Thames H. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 20(17):3651-7, 2002. PMID: 12202666.
- Dalrymple JL, Levenback C, Wolf JK, Bodurka DC, Garcia M, Gershenson DM. Trends among gynecologic oncology inpatient deaths: Is end-of-life care improving?. Gynecol Oncol 85(2):356-61, 2002. PMID: 11972400.
- Crispens MA, Bodurka DC, Deavers M, Lu K, Silva EG, Gershenson DM. Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential. Obstet Gynecol 99(1):3-10, 2002. PMID: 11777502.
- Robinson JB, Singh D, Bodurka-Bevers DC, Wharton JT, Gershenson DM, Wolf JK. Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies. Gynecol Oncol 82(3):550-8, 2001. PMID: 11520154.
- Basen-Engquist K, Bodurka-Bevers D, Fitzgerald MA, Webster K, Cella D, Hu S, Gershenson DM. Reliability and validity of the functional assessment of cancer therapy-ovarian. J Clin Oncol 19(6):1809-17, 2001. PMID: 11251013.
- Gordinier ME, Ramondetta LM, Parker LP, Wolf JK, Follen M, Gershenson DM, Bodurka-Bevers D. Survey of female gynecologic oncologists and fellows: Balancing professional and personal life. Gynecol Oncol 79(2):309-14, 2000. PMID: 11063663.
- Bodurka-Bevers D, Basen-Engquist K, Carmack CL, Fitzgerald MA, Wolf JK, de Moor C, Gershenson DM. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol 78(3 Pt 1):302-8, 2000. PMID: 10985884.
- Bodurka-Bevers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Posttherapy surveillance of women with cervical cancer: An outcomes analysis. Gynecol Oncol 78(2):187-93, 2000. PMID: 10926801.
- Bodurka-Bevers D, Sun CC, Gershenson DM. Pharmacoeconomic considerations in treating ovarian cancer. Pharmacoeconomics 17:133-50, 2000. PMID: 10947337.
Invited Articles
- Bodurka DC, Sun CC. Sexual function after gynecologic cancer. Obstet Gynecol Clin North Am 33(4):621-30, ix, 2006. PMID: 17116505.
- Sun CC, Frumovitz M, Bodurka DC. Quality of life and gynecologic malignancies. Curr Oncol Rep 7(6):459-65, 2005. PMID: 16221383.
- Sood AK, Abu-Rustum NR, Barakat RR, Bodurka DC, Brown J, Donato ML, Poynor EA, Wolf JK, Gershenson DM. Fifth International Conference on Ovarian Cancer: Challenges and opportunities. Gynecol Oncol 97(3):916-23, 2005. PMID: 15907981.
Manuals, Teaching Aids, Other Teaching Publications
- . Survivorship in Gynecologic Cancers, Gynecologic Cancer Foundation's State of the State Report, 2009.
- . Ovarian Cancer: Quality of Life Issues. National Ovarian Cancer Coalition, 2005.
- . Helping Cancer Patients with Quality of Life Treatment Decisions, American College of Obstetricians and Gynecologists ACOG Update, 2005.
- . New Diagnostic Tools on the Horizon: Supplement to The Washington Post sponsored by Gynecologic Cancer Foundation, 2002.
- . MD Anderson Gynecologic Oncology Handbook, 1996.
Other Articles
- Bruegl AS, Ring KL, Daniels M, Fellman BM, Urbauer DL, Broaddus RR Clinical Challenges Associated with Universal Screening for Lynch Syndrome-Associated Endometrial Cancer. Cancer Prev Res (Phila) 10(2):108-115, 2017. PMID: 27965287.
Abstracts
- Langabeer, DM, Krause, T, Cazaban, CMG, Swartz, MD, Lopez, DS, Bodurka DC. Are symptoms distinguishable in ovarian cancer? A nested case control study of insurance claims. Journal of Clinical Oncology 38(15 Supplement S), 2020.
- Chelariu-Raicu, A, Levenback, CF, Slomovitz, BM, Bodurka DC, Gershenson, DM, Coleman, RL. Phase I/II study of weekly topotecan and gefitinib in patients with platinum-resistant ovarian, peritoneal, or fallopian tube cancer. Journal of Clinical Oncology 38(15 Supplement S), 2020.
- Coleman, RL, Hu, W, Soliman, PT, Nick, AM, Ramirez, PT, Westin, SN, Zu, Z, Schmeler, KM, Bodurka DC, Meyer, LA, Sood, AK. Dasatinib, paclitaxel and carboplatin in women with advanced-stage and recurrent endometrial cancer: A pilot clinical and translational study. Gynecologic Oncology 154(Supplement 1):35-36, 2019.
- Zhukovsky DS, Haider A, Naqvi SMAA, Joshi N, Soliman PT, Mathew B, Bodurka DC, Meyer LA, Westin S, Frumovitz M, Archie L, Fenton S, Williams, JL, Boving V. A systematic process to enhance selection of a prepared medical decision maker. Journal of Clinical Oncology 36(34 Supplement S), 2018.
- Taylor JS, Zhang, N, Rajan, SS, Meyer, LA, Ramondetta, LM,Bodurka-Bevers D, Lairson, DR, Giordano, SH. How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients. Gynecologic Oncology 149(Supplement 1):122-122, 2018.
- Michalak, J, Hernandez, M, Laws, A, Jones, L, Bodurka DC, Hajek,R. Potential impact of dietary intervention/counseling on survival in ovarian cancer patients: Results from an observational study. Journal of Clinical Oncology 36(15 Supplement S), 2018.
- Pal N, Broaddus RR, Urbauer DL, Balakrishnan N, Milbourne A, Schmeler KM, Meyer LA, Soliman PT, Lu KH, Ramirez PT, Ramondetta L, Bodurka DC, Westin SN. Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device. Obstet Gynecol 131(1):109-116, 2018. PMID: 29215513.
- J.S. Shaha, Bodurka DC, C.C. Sunb, G. Chisholmb and T.L. Woodard. Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members. Gynecologic Oncology 147(3):497-502, 2017.
- Zhukovsky DS, Soliman, PT, Mathew, B, Mills, S, Bodurka DC, Meyer, L, Westin, SN, Nowitz, M, Archie, L, Fenton, S, Lang, KE, Williams, JL, Boving, V. Selecting a prepared medical decision maker. Journal of Clinical Oncology 35(31 Supplement S), 2017.
- Jolyn S. Taylor, Suja S. Rajan, Ning Zhang, Larissa A. Meyer, Lois M. Ramondetta, Bodurka DC, David R. Lairson, and Sharon H. Giordano. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol 35(16):1829-1835, 2017.
- Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients. Supportive Care in Cancer 25(6):1985-1991, 2017. PMID: 28175997.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Rosemore C, Kolawole E, Sun C, Ramondetta L, Bodurka DC. The Advance Care Planning Readiness Scale: Development and Validation of a Measure of Willingness to Discuss and Acceptance of End-of-Life Care in Gynecologic Cancer Patients. Int J Gynecol Cancer 27(4):838-846, 2017.
- Eileen H. Shinn, Alan Valentine, George Baum, Cindy Carmack, Kelly Kilgore, Bodurka DC, Karen Basen-Engquist. Comparison of four brief depression screening instruments in ovarian cancer patients: Diagnostic accuracy using traditional versus alternative cutpoints. Gynecologic Oncology 145(3):562-568, 2017.
- S.N. Westin, C.C.L. Sun, R. Broaddus, N. Pal, M. Woodall, D. Urbauer, L.M. Ramondetta, K.H. Lu, R.L. Coleman, Bodurka DC. Challenging the paradigm of progesterone-only therapy for early endometrial cancer: Results of a prospective trial of the levonorgestrel intrauterine system. Gynecol Oncol 141(suppl 1):18-19, 2016.
- Taylor JS, Marten CA, Bodurka DC, Burzawa JK, Munsell MF, Potts K, Nick AM, Meyer LA, Levenback CF, Schmeler KM. The DISINFECT initiative: Decreasing the incidence of surgical INFECTions in gynecologic oncology. Gynecol Oncol 141(suppl 1):73, 2016.
- Suidan RS, He W, Sun CC, Zhao H, Ramondetta LM, Badgwell BD, Bodurka DC, Lu KH, Giordano SH, Meyer LA. Treatment patterns and outcomes for bowel obstruction in elderly ovarian cancer patients: A population-based analysis. Gynecol Oncol 141(suppl 1):131, 2016.
- Prescott LS, Vergote IB, Coens C, Sun CC, Munsell MF, Casado A, Coleman RL, Bodurka DC. Effect of perioperative blood transfusion on quality of life, progression-free and overall survival in primary treatment of advanced epithelial ovarian cancer: An EORTC ancillary study. Gynecol Oncol 141(suppl 1):198, 2016.
- Meyer; He, Sun, Zhao, Suidan, Lu, Giordano; Bodurka DC. Uptake and outcomes associated with neoadjuvant chemotherapy in the elderly: a population based analysis. Gynecologic Oncology 141:169, 2016.
- Gershenson DM, Bodurka DC, Coleman RL, Lu KH, Malpica A, Sun CC. Hormaonal maintenance therapy for women with low grade serous carcinoma of the ovary or peritoneum. J Clin Oncol 34, 2016.
- Brown AJ, Shen MJ, Urbauer D, Taylor J, Parker PA, Carmack C, Prescott L, Kolawole E, Rosemore C, Sun C, Ramondetta L, Bodurka DC. Room for improvement: An examination of advance care planning documentation among gynecologic oncology patients. Gynecol Oncol 142(suppl 3):525-530, 2016.
- Brown AJ, Shen MJ, Urbauer D, Taylor JS, Parker P, Carmack C, Prescott LS, Sun CC, Ramondetta LM, Bodurka DC. The Advance Care Planning Readiness Scale: A novel measure of gynecologic oncology patients' willingness to discuss and accept end-of-life care. Gynecol Oncol 141(suppl 1):79-80, 2016.
- Taylor JS, Marten CA, Sun CC, Bodurka DC, Potts K, Nick AM, Meyer LA, Levenback CF, Lairson DR, Schmeler KM. The cost-effectiveness of the DISINFECT Initiative (Decreasing the Incidence of Surgical INFECTions) in gynecologic oncology. Gynecol Oncol 141(supp 1):87, 2016.
- Bruegl AS, Bottsford-Miller JN, Bodurka DC. HPV vaccination practices among American Indian/Alaska Native providers (Poster). Gynecol Oncol 141(suppl 1):132, 2016.
- Meyer LA, He W, Sun CC, Zhao H, Suidan RS, Lu KH, Giordano SH, Bodurka DC. Uptake and outcomes associated with neoadjuvant chemotherapy in the elderly: A population-based analysis. Gynecol Oncol 141(suppl 1):169, 2016.
Book Chapters
- Bodurka DC, Taylor JS. In: Training and Future Leaders In: Ethical Challenges in Oncology. Mosby Elsevier, 2017.
- Shlumbrecht MP, Bodurka DC. Obstetric and Gynecologic Emergencies in Cancer Patients. In: Oncologic Emergencies. Springer, 327-348, 2016.
- Bodurka DC, Frumovitz M. Malignant Diseases of the Vagina. In: Comprehensive Gynecology. 7. Mosby Elsevier, 704-732, 2016.
- Bodurka DC, Frumovitz M. Neoplastic Diseases of the Vulva. In: Comprehensive Gynecology. 7. Mosby Elsevier, 685-703, 2016.
Letters to the Editor
- Slomovitz BM, Bodurka DC, Lu KH. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?. Obstet Gynecol 105: 218-9, 2005.
Grant & Contract Support
| Title: | Prophylactic Mastectomy and Oophorectomy for Women at Risk of Breast and Ovarian Cancer: Incorporating Preferences in a Decision Analysis |
| Funding Source: | PRS Institutional Research Grant |
| Role: | Principal Investigator |
| Title: | Chemoprevention of Ovarian Cancer |
| Funding Source: | U.S. Army (DOD) |
| Role: | Investigator |
| Title: | Specialized Program of Research Excellence in Ovarian Cancer |
| Funding Source: | NIH |
| Role: | Collaborator |
| Title: | The National Ovarian Cancer Early Detection Program |
| Funding Source: | NCI |
| Role: | Co-Investigator |
| Title: | Identifying Factors Associated with Early Detection of Ovarian Cancer |
| Funding Source: | National Center for Chronic Disease Prevention & Health Promotion Centers for Disease Control and Prevention |
| Role: | Co-Investigator |
| Title: | Perceptions of Taxol-Carboplatin Toxicity and Quality of Life Among Ovarian Cancer Patients |
| Funding Source: | Texas Federation of Business and Professional Women |
| Role: | Principal Investigator |
| Title: | Evaluating Patient Preferences Quality of Life and Symptoms of Treatment in Ovarian Cancer Patients Receiving High Dose and Standard Chemotherapy |
| Funding Source: | PRS Institutional Research Grant |
| Role: | Principal Investigator |
| Title: | Modulation of Putative Surrogate End-point BioMarkers in Endometrial Biopsies from Women with HNPCC |
| Funding Source: | NCI/DCP |
| Role: | Co-Investigator |
| Title: | Unrestricted Grant for Quality of Life and Patient Preferences Research |
| Funding Source: | Merck and Company |
| Role: | Investigator |
| Title: | The Elizabeth Registry for the Study of Low-Grade Serous Ovarian Carcinoma |
| Funding Source: | The Elizabeth Fund, Private Philanthropic Funds |
| Role: | Principal Investigator |
| Title: | Chemotherapy-Related Toxicities in Ovarian Cancer Patients: Preference Assessments of Patients |
| Funding Source: | Blanton-Davis Ovarian Cancer Research Program Research Award |
| Role: | Principal Investigator |
| Title: | Sexual Functioning and Quality Of Life in Women with Cervical Cancer |
| Funding Source: | NIH |
| Role: | Principal Investigator |
| Title: | |
| Funding Source: | MD Anderson Cancer Gynecologic SPORE for Uterine Cancer |
| Role: | Co-Investigator |
| Title: | Career Development Core |
| Funding Source: | MD Anderson Cancer Gynecologic SPORE for Uterine Cancer |
| Role: | Consultant |
| Title: | Depression Screening and Treatment in Ovarian Cancer |
| Funding Source: | NCI |
| Role: | Co-Investigator |
| Title: | Training of Academic Gynecologic Oncologists |
| Funding Source: | NIH/NCI |
| Role: | Principal Investigator |
| Title: | Study of Women at Increased Risk of Breast and Ovarian Cancer |
| Funding Source: | The Ellwood Foundation |
| Role: | Principal Investigator |
| Title: | WRHR Program |
| Funding Source: | Baylor College of Medicine |
| Role: | Mentor |
| Title: | Specialized Program of Research Excellence in Uterine Cancer Career Development Award |
| Funding Source: | NIH/NCI |
| Role: | Mentor |
| Title: | A Phase II Study of Irofulven (IND #48914) in Patients with Refractory or Recurrent Advanced Epithelial Ovarian Cancer Using Every-Other-Week Dosing |
| Funding Source: | MGI Pharma |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified August 27, 2024